Bleeding Avoidance Strategies Could Save Hospitals Nearly $5,000 Per PCI
from Cardiovascular Business
Physicians successfully reversed the bleeding risk-treatment paradox in percutaneous coronary intervention (PCI) by prioritizing risk-concordant use of bleeding avoidance strategies (BAS) like bivalirudin, radial access and vascular closure devices, according to a study published Oct. 31 in the Journal of the American Heart Association. The risk-treatment paradox — the idea that patients at the highest risk of bleeding during a PCI procedure paradoxically receive the least amount of BAS — is an important one in PCI, since bleeding is the intervention’s most common complication and affects up to a tenth of its patients each year.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063